{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T04:16:45Z","timestamp":1778991405904,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Amongst other immune cells, neutrophils play a key role in systemic inflammation leading to cardiovascular disease and can release inflammatory factors, including lipocalin-2 (LCN2). LCN2 drives cardiac hypertrophy and plays a role in maladaptive remodelling of the heart and has been associated with renal injury. While lifestyle factors such as diet and exercise are known to attenuate low-grade inflammation, their ability to modulate plasma LCN2 levels is unknown. Forty-eight endurance athletes and 52 controls (18\u201355\u00a0years) underwent measurement for various cardiovascular health indicators, along with plasma LCN2 concentration. No significant difference in LCN2 concentration was seen between the two groups. LCN2 was a very weak predictor or absent from models describing blood pressures or predicting athlete status. In another cohort, 57 non-diabetic overweight or obese men and post-menopausal women who fulfilled Adult Treatment Panel III metabolic syndrome criteria were randomly allocated into either a control, modified Dietary Approaches to Stop Hypertension (DASH) diet, or DASH and exercise group. Pre- and post-intervention demographic, cardiovascular health indicators, and plasma LCN2 expression were measured in each individual. While BMI fell in intervention groups, LCN2 levels remained unchanged within and between all groups, as illustrated by strong correlations between LCN2 concentrations pre- and 12\u00a0weeks post-intervention (<jats:italic>r<\/jats:italic>\u2009=\u20090.743, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). This suggests that circulating LCN2 expression are stable over a period of at least 12\u00a0weeks and is not modifiable by diet and exercise.<\/jats:p>","DOI":"10.1038\/s41598-021-83472-x","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T09:14:59Z","timestamp":1613812499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Plasma lipocalin-2\/NGAL is stable over 12\u00a0weeks and is not modulated by exercise or dieting"],"prefix":"10.1038","volume":"11","author":[{"given":"Michael E.","family":"Nakai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Denham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla R.","family":"Prestes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Eikelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth A.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora E.","family":"Straznicky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus P.","family":"Schlaich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray D.","family":"Esler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan J.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi J.","family":"Charchar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin W.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine Z.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"83472_CR1","doi-asserted-by":"publisher","first-page":"678159","DOI":"10.1155\/2013\/678159","volume":"2013","author":"H Rodr\u00edguez-Hern\u00e1ndez","year":"2013","unstructured":"Rodr\u00edguez-Hern\u00e1ndez, H., Simental-Mend\u00eda, L. E., Rodr\u00edguez-Ram\u00edrez, G. & Reyes-Romero, M. A. Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int. J. Endocrinol. 2013, 678159\u2013678159 (2013).","journal-title":"Int. J. Endocrinol."},{"key":"83472_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor, M. F. & Hotamisligil, G. S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415\u2013445 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"83472_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.atherosclerosis.2017.07.001","volume":"263","author":"A Eltoft","year":"2017","unstructured":"Eltoft, A. et al. C-reactive protein in atherosclerosis\u2014a risk marker but not a causal factor? A 13-year population-based longitudinal study: the Tromso study. Atherosclerosis 263, 293\u2013300 (2017).","journal-title":"Atherosclerosis"},{"key":"83472_CR4","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1161\/CIRCRESAHA.116.309637","volume":"119","author":"A Joshi-Aditya","year":"2016","unstructured":"Joshi-Aditya, A. et al. GlycA is a novel biomarker of inflammation and subclinical cardiovascular disease in psoriasis. Circ. Res. 119, 1242\u20131253 (2016).","journal-title":"Circ. Res."},{"key":"83472_CR5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1161\/CIRCULATIONAHA.114.008788","volume":"131","author":"RA Frieler","year":"2015","unstructured":"Frieler, R. A. & Mortensen, R. M. Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling. Circulation 131, 1019\u20131030 (2015).","journal-title":"Circulation"},{"key":"83472_CR6","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.2337\/diacare.26.10.2764","volume":"26","author":"V Palmieri","year":"2003","unstructured":"Palmieri, V. et al. Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study. Diabetes Care 26, 2764\u20132769 (2003).","journal-title":"Diabetes Care"},{"key":"83472_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1161\/HYPERTENSIONAHA.107.093120","volume":"50","author":"GF Salles","year":"2007","unstructured":"Salles, G. F., Fiszman, R., Cardoso, C. R. & Muxfeldt, E. S. Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension. Hypertension 50, 723\u2013728 (2007).","journal-title":"Hypertension"},{"key":"83472_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","volume":"97","author":"I Shimizu","year":"2016","unstructured":"Shimizu, I. & Minamino, T. Physiological and pathological cardiac hypertrophy. J. Mol. Cell. Cardiol. 97, 245\u2013262 (2016).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"83472_CR9","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/eurheartj\/ehx244","volume":"38","author":"DS Gaul","year":"2017","unstructured":"Gaul, D. S., Stein, S. & Matter, C. M. Neutrophils in cardiovascular disease. Eur. Heart J. 38, 1702\u20131704 (2017).","journal-title":"Eur. Heart J."},{"key":"83472_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1126\/science.1230719","volume":"339","author":"FK Swirski","year":"2013","unstructured":"Swirski, F. K. & Nahrendorf, M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339, 161\u2013166 (2013).","journal-title":"Science"},{"key":"83472_CR11","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.4049\/jimmunol.1200892","volume":"189","author":"G Srinivasan","year":"2012","unstructured":"Srinivasan, G. et al. Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis. J. Immunol. 189, 1911\u20131919 (2012).","journal-title":"J. Immunol."},{"key":"83472_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-nutr-071816-064559","volume":"37","author":"X Xiao","year":"2017","unstructured":"Xiao, X., Yeoh, B. S. & Vijay-Kumar, M. Lipocalin 2: an emerging player in iron homeostasis and inflammation. Annu. Rev. Nutr. 37, 103\u2013130 (2017).","journal-title":"Annu. Rev. Nutr."},{"key":"83472_CR13","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.cca.2011.06.043","volume":"412","author":"G Leoncini","year":"2011","unstructured":"Leoncini, G. et al. Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. Clin. Chim. Acta 412, 1951\u20131956 (2011).","journal-title":"Clin. Chim. Acta"},{"key":"83472_CR14","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/eurjhf\/hfr087","volume":"13","author":"AS Maisel","year":"2011","unstructured":"Maisel, A. S. et al. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur. J. Heart Fail. 13, 846\u2013851 (2011).","journal-title":"Eur. J. Heart Fail."},{"key":"83472_CR15","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1172\/JCI42004","volume":"120","author":"A Viau","year":"2010","unstructured":"Viau, A. et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J. Clin. Investig. 120, 4065\u20134076 (2010).","journal-title":"J. Clin. Investig."},{"key":"83472_CR16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ejvs.2016.01.009","volume":"51","author":"W Eilenberg","year":"2016","unstructured":"Eilenberg, W. et al. Neutrophil gelatinase-associated lipocalin (NGAL) is associated with symptomatic carotid atherosclerosis and drives pro-inflammatory state in vitro. Eur. J. Vasc. Endovasc. Surg. 51, 623\u2013631 (2016).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"83472_CR17","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03104","volume":"432","author":"TH Flo","year":"2004","unstructured":"Flo, T. H. et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917\u2013921 (2004).","journal-title":"Nature"},{"key":"83472_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.advms.2015.01.001","volume":"60","author":"F Liu","year":"2015","unstructured":"Liu, F., Yang, H., Chen, H., Zhang, M. & Ma, Q. High expression of neutrophil gelatinase-associated lipocalin (NGAL) in the kidney proximal tubules of diabetic rats. Adv. Med. Sci. 60, 133\u2013138 (2015).","journal-title":"Adv. Med. Sci."},{"key":"83472_CR19","doi-asserted-by":"publisher","first-page":"e005971","DOI":"10.1161\/JAHA.117.005971","volume":"6","author":"FZ Marques","year":"2017","unstructured":"Marques, F. Z. et al. Experimental and human evidence for lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the development of cardiac hypertrophy and heart failure. J. Am. Heart Assoc. 6, e005971. https:\/\/doi.org\/10.1161\/JAHA.117.005971 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"83472_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pharmthera.2013.03.009","volume":"139","author":"GV Halade","year":"2013","unstructured":"Halade, G. V., Jin, Y. F. & Lindsey, M. L. Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation. Pharmacol. Ther. 139, 32\u201340 (2013).","journal-title":"Pharmacol. Ther."},{"key":"83472_CR21","doi-asserted-by":"publisher","first-page":"37258","DOI":"10.1074\/jbc.M106089200","volume":"276","author":"L Yan","year":"2001","unstructured":"Yan, L., Borregaard, N., Kjeldsen, L. & Moses, M. A. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B\/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J. Biol. Chem. 276, 37258\u201337265 (2001).","journal-title":"J. Biol. Chem."},{"key":"83472_CR22","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.3390\/nu5093646","volume":"5","author":"S Eilat-Adar","year":"2013","unstructured":"Eilat-Adar, S., Sinai, T., Yosefy, C. & Henkin, Y. Nutritional recommendations for cardiovascular disease prevention. Nutrients 5, 3646\u20133683 (2013).","journal-title":"Nutrients"},{"key":"83472_CR23","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1038\/oby.2011.76","volume":"20","author":"KE Foster-Schubert","year":"2012","unstructured":"Foster-Schubert, K. E. et al. Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women. Obesity (Silver Spring, Md.) 20, 1628\u20131638 (2012).","journal-title":"Obesity (Silver Spring, Md.)"},{"key":"83472_CR24","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1161\/01.CIR.102.12.1358","volume":"102","author":"SG Wannamethee","year":"2000","unstructured":"Wannamethee, S. G., Shaper, A. G. & Walker, M. Physical activity and mortality in older men with diagnosed coronary heart disease. Circulation 102, 1358\u20131363 (2000).","journal-title":"Circulation"},{"key":"83472_CR25","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.nut.2012.11.020","volume":"29","author":"Z Asemi","year":"2013","unstructured":"Asemi, Z., Samimi, M., Tabassi, Z., Sabihi, S. S. & Esmaillzadeh, A. A randomized controlled clinical trial investigating the effect of DASH diet on insulin resistance, inflammation, and oxidative stress in gestational diabetes. Nutrition (Burbank, Los Angeles County, Calif.) 29, 619\u2013624 (2013).","journal-title":"Nutrition (Burbank, Los Angeles County, Calif.)"},{"key":"83472_CR26","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1017\/S0007114511004193","volume":"106","author":"PC Calder","year":"2011","unstructured":"Calder, P. C. et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nutr. 106, S1\u2013S78 (2011).","journal-title":"Br. J. Nutr."},{"key":"83472_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/CIRCULATIONAHA.115.018585","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Mozaffarian, D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation 133, 187\u2013225 (2016).","journal-title":"Circulation"},{"key":"83472_CR28","first-page":"4762575","volume":"2018","author":"BKS Silveira","year":"2018","unstructured":"Silveira, B. K. S. et al. Dietary pattern and macronutrients profile on the variation of inflammatory biomarkers: scientific update. Cardiol. Res. Pract. 2018, 4762575 (2018).","journal-title":"Cardiol. Res. Pract."},{"key":"83472_CR29","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3945\/an.115.009415","volume":"6","author":"A Smidowicz","year":"2015","unstructured":"Smidowicz, A. & Regula, J. Effect of nutritional status and dietary patterns on human serum C-reactive protein and interleukin-6 concentrations. Adv. Nutr. (Bethesda, Md.) 6, 738\u2013747 (2015).","journal-title":"Adv. Nutr. (Bethesda, Md.)"},{"key":"83472_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2337\/db09-0934","volume":"59","author":"NE Straznicky","year":"2010","unstructured":"Straznicky, N. E. et al. Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes 59, 71\u201379 (2010).","journal-title":"Diabetes"},{"key":"83472_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cardfail.2009.07.003","volume":"16","author":"A Aghel","year":"2010","unstructured":"Aghel, A., Shrestha, K., Mullens, W., Borowski, A. & Tang, W. H. W. Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J. Cardiac Fail. 16, 49\u201354 (2010).","journal-title":"J. Cardiac Fail."},{"key":"83472_CR32","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1053\/j.ajkd.2008.01.020","volume":"52","author":"D Bolignano","year":"2008","unstructured":"Bolignano, D. et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am. J. Kidney Dis. 52, 595\u2013605 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"83472_CR33","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1136\/heart.89.12.1455","volume":"89","author":"R Fagard","year":"2003","unstructured":"Fagard, R. Athlete\u2019s heart.  Heart (Br. Cardiac Soc.) 89, 1455\u20131461 (2003).","journal-title":"Heart (Br. Cardiac Soc.)"},{"key":"83472_CR34","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.mayocp.2014.06.004","volume":"89","author":"N Garatachea","year":"2014","unstructured":"Garatachea, N. et al. Elite athletes live longer than the general population: a meta-analysis. Mayo Clin. Proc. 89, 1195\u20131200 (2014).","journal-title":"Mayo Clin. Proc."},{"key":"83472_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40798-015-0024-x","volume":"1","author":"S Lemez","year":"2015","unstructured":"Lemez, S. & Baker, J. Do elite athletes live longer? A systematic review of mortality and longevity in elite athletes. Sports Med. Open 1, 16 (2015).","journal-title":"Sports Med. Open"},{"key":"83472_CR36","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1123\/ijspp.2016-0471","volume":"12","author":"CA Muniesa","year":"2017","unstructured":"Muniesa, C. A. et al. Telomere length in elite athletes. Int. J. Sports Physiol. Perform. 12, 994\u2013996 (2017).","journal-title":"Int. J. Sports Physiol. Perform."},{"key":"83472_CR37","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1055\/s-0043-120345","volume":"38","author":"HG Simoes","year":"2017","unstructured":"Simoes, H. G. et al. Longer telomere length in elite master sprinters: relationship to performance and body composition. Int. J. Sports Med. 38, 1111\u20131116 (2017).","journal-title":"Int. J. Sports Med."},{"key":"83472_CR38","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jsams.2009.04.010","volume":"13","author":"M Teramoto","year":"2010","unstructured":"Teramoto, M. & Bungum, T. J. Mortality and longevity of elite athletes. J. Sci. Med. Sport 13, 410\u2013416 (2010).","journal-title":"J. Sci. Med. Sport"},{"key":"83472_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molmet.2019.09.009","volume":"30","author":"K Chella-Krishnan","year":"2019","unstructured":"Chella-Krishnan, K. et al. Sex-specific metabolic functions of adipose Lipocalin-2. Mol. Metab. 30, 30\u201347 (2019).","journal-title":"Mol. Metab."},{"key":"83472_CR40","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1586\/17446651.1.6.783","volume":"1","author":"AC Hackney","year":"2006","unstructured":"Hackney, A. C. Stress and the neuroendocrine system: the role of exercise as a stressor and modifier of stress. Expert Rev. Endocrinol. Metab. 1, 783\u2013792 (2006).","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"83472_CR41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1113\/EP086025","volume":"102","author":"LM JanssenDuijghuijsen","year":"2017","unstructured":"JanssenDuijghuijsen, L. M. et al. Adaptation of exercise-induced stress in well-trained healthy young men. Exp. Physiol. 102, 86\u201399 (2017).","journal-title":"Exp. Physiol."},{"key":"83472_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00042752-200101000-00007","volume":"11","author":"KE Fallon","year":"2001","unstructured":"Fallon, K. E. The acute phase response and exercise: the ultramarathon as prototype exercise. Clin. J. Sport Med. 11, 38\u201343 (2001).","journal-title":"Clin. J. Sport Med."},{"key":"83472_CR43","first-page":"829","volume":"31","author":"A Andreazzoli","year":"2017","unstructured":"Andreazzoli, A. et al. Assessment of pN-GAL as a marker of renal function in elite cyclists during professional competitions. J. Biol. Regul. Homeost. Agents 31, 829\u2013835 (2017).","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"83472_CR44","first-page":"1585","volume":"50","author":"G Lippi","year":"2012","unstructured":"Lippi, G. et al. Variation of serum and urinary neutrophil gelatinase associated lipocalin (NGAL) after strenuous physical exercise. Clin. Chem. Lab. Med. (CCLM) 50, 1585 (2012).","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"83472_CR45","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1123\/jpah.2017-0496","volume":"15","author":"JCQ Machado","year":"2018","unstructured":"Machado, J. C. Q., Volpe, C. M. O., Vasconcellos, L. S. & Nogueira-Machado, J. A. Quantification of NGAL in urine of endurance cycling athletes.  J. Phys. Activ. Health 15, 679 (2018).","journal-title":"J. Phys. Activ. Health"},{"key":"83472_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1373\/clinchem.2006.075614","volume":"53","author":"Y Wang","year":"2007","unstructured":"Wang, Y. et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin. Chem. 53, 34\u201341 (2007).","journal-title":"Clin. Chem."},{"key":"83472_CR47","first-page":"1101","volume":"59","author":"LB Daniels","year":"2012","unstructured":"Daniels, L. B. et al. Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults. Rancho Bernardo Study 59, 1101\u20131109 (2012).","journal-title":"Rancho Bernardo Study"},{"key":"83472_CR48","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/oby.2011.61","volume":"19","author":"T Auguet","year":"2011","unstructured":"Auguet, T. et al. Upregulation of lipocalin 2 in adipose tissues of severely obese women: positive relationship with proinflammatory cytokines. Obesity (Silver Spring, Md.) 19, 2295\u20132300 (2011).","journal-title":"Obesity (Silver Spring, Md.)"},{"key":"83472_CR49","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13104-017-2604-y","volume":"10","author":"AE Elkhidir","year":"2017","unstructured":"Elkhidir, A. E., Eltaher, H. B. & Mohamed, A. O. Association of lipocalin-2 level, glycemic status and obesity in type 2 diabetes mellitus. BMC Res. Notes 10, 285 (2017).","journal-title":"BMC Res. Notes"},{"key":"83472_CR50","doi-asserted-by":"publisher","first-page":"e4039","DOI":"10.1097\/MD.0000000000004039","volume":"95","author":"Y Luo","year":"2016","unstructured":"Luo, Y. et al. Serum lipocalin-2 levels are positively associated with not only total body fat but also visceral fat area in Chinese men. Medicine 95, e4039 (2016).","journal-title":"Medicine"},{"key":"83472_CR51","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1161\/ATVBAHA.114.303718","volume":"34","author":"G Wu","year":"2014","unstructured":"Wu, G. et al. Elevated circulating lipocalin-2 levels independently predict incident cardiovascular events in men in a population-based cohort. Arterioscler. Thromb. Vasc. Biol. 34, 2457\u20132464 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"83472_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.hgmx.2016.06.011","volume":"80","author":"AM Castro","year":"2017","unstructured":"Castro, A. M., Macedo-de la Concha, L. E. & Pantoja-Mel\u00e9ndez, C. A. Low-grade inflammation and its relation to obesity and chronic degenerative diseases. Revista M\u00e9dica del Hospital General de M\u00e9xico 80, 101\u2013105 (2017).","journal-title":"Revista M\u00e9dica del Hospital General de M\u00e9xico"},{"key":"83472_CR53","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.2337\/dc05-2327","volume":"29","author":"N de Rekeneire","year":"2006","unstructured":"de Rekeneire, N. et al. Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study. Diabetes Care 29, 1902\u20131908 (2006).","journal-title":"Diabetes Care"},{"key":"83472_CR54","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1530\/JOE-14-0283","volume":"222","author":"M Mraz","year":"2014","unstructured":"Mraz, M. & Haluzik, M. The role of adipose tissue immune cells in obesity and low-grade inflammation.  J. Endocrinol. 222, R113 (2014).","journal-title":"J. Endocrinol."},{"key":"83472_CR55","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1152\/japplphysiol.00518.2014","volume":"119","author":"SS Angadi","year":"2015","unstructured":"Angadi, S. S. et al. High-intensity interval training vs. moderate-intensity continuous exercise training in heart failure with preserved ejection fraction: a pilot study. J. Appl. Physiol. 119, 753\u2013758 (2015).","journal-title":"J. Appl. Physiol."},{"key":"83472_CR56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1440-1681.2007.04585.x","volume":"34","author":"JR McMullen","year":"2007","unstructured":"McMullen, J. R. & Jennings, G. L. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin. Exp. Pharmacol. Physiol. 34, 255\u2013262 (2007).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"83472_CR57","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.mce.2006.03.017","volume":"252","author":"A Keren","year":"2006","unstructured":"Keren, A., Tamir, Y. & Bengal, E. The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol. Cell. Endocrinol. 252, 224\u2013230 (2006).","journal-title":"Mol. Cell. Endocrinol."},{"key":"83472_CR58","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1152\/japplphysiol.00085.2007","volume":"103","author":"HF Kramer","year":"2007","unstructured":"Kramer, H. F. & Goodyear, L. J. Exercise, MAPK, and NF-\u03baB signaling in skeletal muscle. J. Appl. Physiol. 103, 388\u2013395 (2007).","journal-title":"J. Appl. Physiol."},{"key":"83472_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fcell.2016.00091","volume":"4","author":"J Segales","year":"2016","unstructured":"Segales, J., Perdiguero, E. & Munoz-Canoves, P. Regulation of muscle stem cell functions: a focus on the p38 MAPK signaling pathway. Front. Cell Dev. Biol. 4, 91 (2016).","journal-title":"Front. Cell Dev. Biol."},{"key":"83472_CR60","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/oby.2011.61","volume":"19","author":"T Auguet","year":"2011","unstructured":"Auguet, T. et al. Upregulation of lipocalin 2 in adipose tissues of severely obese women: positive relationship with proinflammatory cytokines. Obesity 19, 2295\u20132300 (2011).","journal-title":"Obesity"},{"key":"83472_CR61","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5223\/pghn.2013.16.3.143","volume":"16","author":"H Lee","year":"2013","unstructured":"Lee, H., Lee, I. S. & Choue, R. Obesity, inflammation and diet. Pediatr. Gastroenterol. Hepatol. Nutr. 16, 143\u2013152 (2013).","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"83472_CR62","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1210\/jcem.85.3.6355","volume":"85","author":"RH Straub","year":"2000","unstructured":"Straub, R. H. et al. Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J. Clin. Endocrinol. Metab. 85, 1340\u20131344 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"83472_CR63","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s00421-016-3407-x","volume":"116","author":"J Denham","year":"2016","unstructured":"Denham, J. et al. Aortic augmentation index in endurance athletes: a role for cardiorespiratory fitness. Eur. J. Appl. Physiol. 116, 1537\u20131544 (2016).","journal-title":"Eur. J. Appl. Physiol."},{"key":"83472_CR64","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1152\/japplphysiol.00587.2015","volume":"120","author":"J Denham","year":"2016","unstructured":"Denham, J., O\u2019Brien, B. J., Prestes, P. R., Brown, N. J. & Charchar, F. J. Increased expression of telomere-regulating genes in endurance athletes with long leukocyte telomeres. J. Appl. Physiol. (Bethesda, Md.: 1985) 120, 148\u2013158 (2016).","journal-title":"J. Appl. Physiol. (Bethesda, Md.: 1985)"},{"key":"83472_CR65","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","volume":"336","author":"LJ Appel","year":"1997","unstructured":"Appel, L. J. et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 336, 1117\u20131124 (1997).","journal-title":"N. Engl. J. Med."},{"key":"83472_CR66","doi-asserted-by":"publisher","first-page":"5998","DOI":"10.1210\/jc.2005-0961","volume":"90","author":"NE Straznicky","year":"2005","unstructured":"Straznicky, N. E. et al. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J. Clin. Endocrinol. Metab. 90, 5998\u20136005 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"83472_CR67","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/01.HYP.18.5.575","volume":"18","author":"IT Meredith","year":"1991","unstructured":"Meredith, I. T. et al. Exercise training lowers resting renal but not cardiac sympathetic activity in humans. Hypertension 18, 575\u2013582 (1991).","journal-title":"Hypertension"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83472-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83472-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83472-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:43:34Z","timestamp":1670039014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83472-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83472"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83472-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"assertion":[{"value":"6 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MPS has received research support from Medtronic, Abbott, Novartis, Servier, Pfizer, and Boehringer-Ingelheim. GWL has acted as a consultant for Medtronic. FZM is supported by a National Heart Foundation Future Leader Fellowship, a National Health and Medical Research Council Project Grant and a National Heart Foundation Vanguard Grant. GWL, NE and EAL are supported by Swinburne Research, Swinburne University of technology. MPS is supported by an NHMRC Research Fellowship. All other authors declare no competing interests. Data used in this manuscript is available upon request.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4056"}}